Executive Summary

The Las Vegas-based firm says its hand sanitizer lotion DermSafe kills/inactivates the H1N1 virus to the same detection level as 70 percent alcohol, as demonstrated in clinical tests by Bioscience Laboratories. Skinvisible says the outcome confirms an in-vitro study conducted at the European contract research organization Retroscreen Virology, which found the product kills/inactivates 99.9 percent of H1N1. The firm adds the study "proves that Dermsafe is an effective alternative to alcohol, without the drying and safety issues." The sanitizer uses the firm's Invisicare polymer delivery system that binds to skin, resisting wash-off for up to four hours. FDA and the Federal Trade Commission have joined forces to crack down on marketing unapproved products making H1N1 claims (1"The Tan Sheet" Oct. 19, 2009)